Clinical definitions of melioidosis

American Journal of Tropical Medicine and Hygiene

Volumn 88, Issue 3, 2013, Pages 411-413

  Cheng, Allen C ^a   Currie, Bart J ^b   Dance, David A B ^c   Funnell, Simon G P ^d   Limmathurotsakul, Direk ^e   Simpson, Andrew J H ^f   Peacock, Sharon J ^g  

^a MONASH UNIVERSITY   (Australia)

^b MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^c MAHOSOT HOSPITAL   (Laos)

^d PUBLIC HEALTH ENGLAND   (United Kingdom)

^e MAHIDOL UNIVERSITY   (Thailand)

^f DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

^g UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTATION; BACTERIUM CULTURE; BURKHOLDERIA PSEUDOMALLEI; CHRONIC KIDNEY DISEASE; CHRONIC LUNG DISEASE; CLINICAL FEATURE; CLINICAL PRACTICE; COUGHING; DIABETES MELLITUS; DYSPNEA; HOSPITAL ADMISSION; HUMAN; INHALATIONAL MELIOIDOSIS; MELIOIDOSIS; NONHUMAN; PRACTICE GUIDELINE; REVIEW; SENSITIVITY AND SPECIFICITY; SEPSIS; SEROLOGY; THALASSEMIA; THORAX PAIN; THORAX RADIOGRAPHY; ARTICLE; BACTERIAL PNEUMONIA; BIOLOGICAL WARFARE; EXPOSURE; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PATHOLOGY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

BACTERIOLOGICAL TECHNIQUES; BIOTERRORISM; BURKHOLDERIA PSEUDOMALLEI; HUMANS; INHALATION EXPOSURE; MELIOIDOSIS; PNEUMONIA, BACTERIAL; SENSITIVITY AND SPECIFICITY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

MLCS; MLOWN;

EID: 84877092802     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.12-0555     Document Type: Review

References (20)

1. Wuthiekanun V, Suputtamongkol Y, Simpson AJ, Kanaphun P, White NJ, 2001. Value of throat swab in diagnosis of melioidosis. J Clin Microbiol 39: 3801-3802. (Pubitemid 32954553)
2. Limmathurotsakul D, Jamsen K, Arayawichanont A, Simpson JA, White LJ, Lee SJ, Wuthiekanun V, Chantratita N, Cheng A, Day NP, Verzilli C, Peacock SJ, 2010. Defining the true sensitivity of culture for the diagnosis of melioidosis using Bayesian latent class models. PLoS One 5: e12485.
3. Wuthiekanun V, Chierakul W, Langa S, Chaowagul W, Panpitpat C, Saipan P, Thoujaikong T, Day NP, Peacock SJ, 2006. Development of antibodies to Burkholderia pseudomallei during childhood in melioidosis-endemic northeast Thailand. Am J Trop Med Hyg 74: 1074-1075. (Pubitemid 351627418)
4. Cheng AC, O'Brien M, Freeman K, Lum G, Currie BJ, 2006. Indirect hemagglutination assay in patients with melioidosis in northern Australia. Am J Trop Med Hyg 74: 330-334. (Pubitemid 46774349)
5. Peacock SJ, Schweizer HP, Dance DA, Smith TL, Gee JE, Wuthiekanun V, DeShazer D, Steinmetz I, Tan P, Currie BJ, 2008. Management of accidental laboratory exposure to Burkholderia pseudomallei and B. mallei. Emerg Infect Dis 14: e2. (Pubitemid 351920471)
6. Chantratita N, Wuthiekanun V, Limmathurotsakul D, Thanwisai A, Chantratita W, Day NP, Peacock SJ, 2007. Prospective clinical evaluation of the accuracy of 16S rRNA real-time PCR assay for the diagnosis of melioidosis. Am J Trop Med Hyg 77: 814-817. (Pubitemid 351837820)
7. Richardson LJ, Kaestli M, Mayo M, Bowers JR, Tuanyok A, Schupp J, Engelthaler D, Wagner DM, Keim PS, Currie BJ, 2012. Towards a rapid molecular diagnostic for melioidosis: comparison of DNA extraction methods from clinical specimens. J Microbiol Methods 88: 179-181.
8. Kaestli M, Richardson LJ, Colman RE, Tuanyok A, Price EP, Bowers JR, Mayo M, Kelley E, Seymour ML, Sarovich DS, Pearson T, Engelthaler DM, Wagner DM, Keim PS, Schupp JM, Currie BJ, 2012. Comparison of TaqMan PCR assays for detection of the melioidosis agent Burkholderia pseudomallei in clinical specimens. J Clin Microbiol 50: 2059-2062.
9. Bowers JR, Engelthaler DM, Ginther JL, Pearson T, Peacock SJ, Tuanyok A, Wagner DM, Currie BJ, Keim PS, 2010. BurkDiff: a real-time PCR allelic discrimination assay for Burkholderia pseudomallei and B. mallei. PLoS One 5: e15413.
10. Currie BJ, Fisher DA, Anstey NM, Jacups SP, 2000. Melioidosis: acute and chronic disease, relapse and re-activation. Trans R Soc Trop Med Hyg 94: 301-304. (Pubitemid 30406565)
11. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ Jr; Recombinant Human Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) Study Group, 2001. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344: 699-709. (Pubitemid 32204987)
12. Currie BJ, Ward L, Cheng AC, 2010. The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year Darwin prospective study. PLoS Negl Trop Dis 4: e900.
13. Nelson M, Dean RE, Salguero FJ, Taylor C, Pearce PC, Simpson AJ, Lever MS, 2011. Development of an acute model of inhalational melioidosis in the common marmoset (Callithrix jacchus). Int J Exp Pathol 92: 428-435.
14. ACCP/SCCM, 1992. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20: 864-874.
15. Meumann EM, Cheng AC, Ward L, Currie BJ, 2012. Clinical features and epidemiology of melioidosis pneumonia: results from a 21-year study and review of the literature. Clin Infect Dis 54: 362-369.
16. Howe C, Sampath A, Spotnitz M, 1971. The pseudomallei group: a review. J Infect Dis 124: 598-606.
17. Currie BJ, Jacups SP, 2003. Intensity of rainfall and severity of melioidosis, Australia. Emerg Infect Dis 9: 1538-1542. (Pubitemid 37505447)
18. Nigg C, Ruch J, Scott E, Noble K, 1956. Enhancement of virulence of Malleomyces pseudomallei. J Bacteriol 71: 530-541.
19. Jeddeloh JA, Fritz DL, Waag DM, Hartings JM, Andrews GP, 2003. Biodefense-driven murinemodel of pneumonicmelioidosis. Infect Immun 71: 584-587.
20. Huis in 't Veld D, Wuthiekanun V, Cheng AC, Chierakul W, Chaowagul W, Brouwer AE, White NJ, Day NP, Peacock SJ, 2005. The role and significance of sputum cultures in the diagnosis of melioidosis. Am J Trop Med Hyg 73: 657-661. (Pubitemid 41446708)